Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8722400 Artificial antigen presenting cells and uses therefor
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
June 8, 2010
Date of Patent
May 13, 2014
Patent Application Number
12796445
Patent Citations Received
US Patent 12128069 Treatment of cancer using chimeric antigen receptor and protein kinase a blocker
0
US Patent 11999802 Compositions and methods for selective protein degradation
0
US Patent 11999794 Human mesothelin chimeric antigen receptors and uses thereof
0
US Patent 12091681 Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
0
US Patent 11747346 Biomarkers predictive of cytokine release syndrome
US Patent 11851659 Compositions and methods for immunooncology
0
US Patent 11865167 Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
0
US Patent 11872249 Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain
0
US Patent RE49847 Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
0
US Patent 11919946 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
8722400
Patent Primary Examiner
Q. Janice Li
Find more entities like US Patent 8722400 Artificial antigen presenting cells and uses therefor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE